Invitro Toxicology Testing market by product, technique, application and end-user and Geography. Key Players are Cyprotex, GE Healthcare, Covance, Thermo Fisher Scientific, Eurofins Scientific, Promega Corporation, SGS, Merck, Lonza and Charles River Labo

Precision Business Insights (PBI) in its report titled “Invitro Toxicology Testing Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2018 and Forecast 2019-2025” assesses the market performance over seven years forecast period from 2019 to 2025. The report analyses the market value forecast and provides the strategic insights into the market driving factors, challenges that are hindering the in vitro toxicology testing market revenue growth over forecast period.

The Invitro Toxicology market size was accounted for US$ XX Mn in 2018 and anticipated to account for US$ XX Mn by 2025. Increase in advanced technologies, rise in R&D activities in cell cultures, rise in demand for in vitro toxicology tests will create a demand for the growth of Invitro toxicology testing market. On the other hand, stringent regulatory framework, scarcity of in vitro models to detect auto immunity and immune stimulation, technological disadvantages are restraints of the in vitro toxicology testing market.

Invitro toxicology testing market segmented on the basis of product, technique, application and end user.

Systemic Toxicology Segment Expected to Dominate the Market

On the basis of application, the in-vitro toxicology testing market has been segmented into systemic toxicology, dermal toxicology, endocrine disruption, ocular toxicity, and others. Systemic toxicology is poised to dominate the market while the others segment is anticipated to post the highest CAGR during the forecast period.

Read more Insights at https://precisionbusinessinsights.com/market-reports/in-vitro-toxicology-market/

Cellular Assay Will Dominate the Revenue Share.

Based on method, invitro toxicology testing market is segmented into ex vivo models, cellular assays, and biochemical Assays. Cellular assay represented the largest share in terms of revenue owing to presence of wide product portfolio of cellular techniques for pharmacovigilance study of drug products. Moreover, presence of a significant number of biotechnology companies that are heavily dependent on cell-based assays to conduct their research activities is playing an important role in propelling the growth of the segment.
Europe, Accounts for Major Revenue Share for Invitro Toxicology Testing Market

Precision Business Insights (PBI), Invitro Toxicology market report analyses the market in different regions North America, Europe, Asia Pacific, Latin America and Middle East and Africa. According to regional analysis, Europe accounted for major revenue share due to surge in cosmetic product testing, favorable support from government. Asia Pacific region is expected to show rapid growth rate owing to burgeoning medical tourism in emerging countries, increase in disposable income, low cost of developments, increase in investments and large pool of population.

Strategic Collaboration Play Vital Role in Invitro Toxicology Testing Market

Market strategies such as collaboration play an important role in the growth of invitro toxicology testing market. For instance, in September 2017, Aspect Biosystems entered into collaboration with InSCREENeX GmbH and Fraunhofer ITEM (Institute of Toxicology and Experimental Medicine) for application of Lab on a Printer Bio Printing technology to create novel tissues that can be used to improve the reliability of pre-clinical toxicity testing.

Request sample brochure of the report at https://precisionbusinessinsights.com/request-sample?product_id=19052

Key players in the market include Cyprotex (Germany), GE Healthcare (U.S.), Covance (U.S.), Thermo Fisher Scientific (U.S.), Eurofins Scientific SE (Luxembourg), Promega Corporation (U.S.), SGS SA (Switzerland), Merck KGaA (Germany), Lonza Group Ltd. (Switzerland), Charles River Laboratories, Inc. (U.S.).

Detailed Segmentation

By Product Type

o Bacterial Toxicity Assays
o Enzyme Toxicity Assays
o Tissue Culture Assays
o Western Blots
o Cell Based ELISA
o Receptor Binding Assays

By Technology

o Cellular Imaging Technology
o High Throughput Technology
o Toxic Genomics
o Cell Culture Technology

By Application

o Skin Sensitization and Irritation
o Cytotoxicity
o Neurotoxicity
o Genotoxicity
o Ocular toxicity
o Phototoxicity
o Carcinogenicity
o Organ toxicity
o Dermal toxicity

By End Users

o Pharmaceutical Industry
o Biopharmaceutical Industry
o Cosmetics Industry
o Chemicals Industry
o Food Industry

By Method

o Ex Vivo Models
o Cellular Assays
o Biochemical Assays

Geography

o North America
 U.S.
 Canada
o Europe
 Germany
 UK
 France
 Russia
 Spain
 Italy
 Rest of Europe
o Asia-Pacific
 China
 Japan
 India
 ASEAN
 Rest of Asia Pacific
o Latin America
 Brazil
 Mexico
 Argentina
 Chile
 Rest of Latin America
o Middle East and Africa
 South Africa
 Gulf Cooperation Council Countries(GCCC)
 Rest of MEA

About Precision Business Insights
Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Contact us
Kemp House,
152 – 160 City Road,
London EC1V 2NX
Email: sales@precisionbusinessinsights.com
Toll Free (US):+1-866-598-1553
Website @https://www.precisionbusinessinsights.com

This release was published on openPR.